Published in Healthcare Finance, Tax and Law Weekly, August 30th, 2006
Study 1: Pharmacological preconditioning in rat myocardium induced by 3-nitropropionic acid is associated with increased NO bioavailability and reduced peroxynitrite formation.
According to a study from Turkey, "3-nitropropionic acid (3-NP), an irreversible inhibitor of succinate dehydrogenase, has been shown to protect against ischemic injury in the brain and in the heart via a preconditioning-like effect; however, the cellular mechanism is not known. The aim of the present study was to investigate if 3-NP pretreatment reduces infarct size and if altered...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.